Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
NK cell defects in X-linked pigmentary reticulate disorder
Petro Starokadomskyy, Katelynn M. Wilton, Konrad Krzewski, Adam Lopez, Luis Sifuentes-Dominguez, Brittany Overlee, Qing Chen, Ann Ray, Aleksandra Gil-Krzewska, Mary Peterson, Lisa N. Kinch, Luis Rohena, Eyal Grunebaum, Andrew R. Zinn, Nick V. Grishin, Daniel D. Billadeau, Ezra Burstein
Petro Starokadomskyy, Katelynn M. Wilton, Konrad Krzewski, Adam Lopez, Luis Sifuentes-Dominguez, Brittany Overlee, Qing Chen, Ann Ray, Aleksandra Gil-Krzewska, Mary Peterson, Lisa N. Kinch, Luis Rohena, Eyal Grunebaum, Andrew R. Zinn, Nick V. Grishin, Daniel D. Billadeau, Ezra Burstein
View: Text | PDF
Research Article Infectious disease Inflammation

NK cell defects in X-linked pigmentary reticulate disorder

  • Text
  • PDF
Abstract

X-linked reticulate pigmentary disorder (XLPDR, Mendelian Inheritance in Man #301220) is a rare syndrome characterized by recurrent infections and sterile multiorgan inflammation. The syndrome is caused by an intronic mutation in POLA1, the gene encoding the catalytic subunit of DNA polymerase-α (Pol-α), which is responsible for Okazaki fragment synthesis during DNA replication. Reduced POLA1 expression in this condition triggers spontaneous type I interferon expression, which can be linked to the autoinflammatory manifestations of the disease. However, the history of recurrent infections in this syndrome is as yet unexplained. Here we report that patients with XLPDR have reduced NK cell cytotoxic activity and decreased numbers of NK cells, particularly differentiated, stage V, cells (CD3–CD56dim). This phenotype is reminiscent of hypomorphic mutations in MCM4, which encodes a component of the minichromosome maintenance (MCM) helicase complex that is functionally linked to Pol-α during the DNA replication process. We find that POLA1 deficiency leads to MCM4 depletion and that both can impair NK cell natural cytotoxicity and show that this is due to a defect in lytic granule polarization. Altogether, our study provides mechanistic connections between Pol-α and the MCM complex and demonstrates their relevance in NK cell function.

Authors

Petro Starokadomskyy, Katelynn M. Wilton, Konrad Krzewski, Adam Lopez, Luis Sifuentes-Dominguez, Brittany Overlee, Qing Chen, Ann Ray, Aleksandra Gil-Krzewska, Mary Peterson, Lisa N. Kinch, Luis Rohena, Eyal Grunebaum, Andrew R. Zinn, Nick V. Grishin, Daniel D. Billadeau, Ezra Burstein

×

Figure 3

POLA1 deficiency affects NK cell maturation and direct cytotoxicity.

Options: View larger image (or click on image) Download as PowerPoint
POLA1 deficiency affects NK cell maturation and direct cytotoxicity.
(A)...
(A) Flow cytometry quantification of the CD56dim/CD56bright ratio in peripheral NK cells is significantly affected in XLPDR patients (P1–P5) compared with unaffected control (UA1–UA7, UA10, UA11). Horizontal bars represent the mean; error bars correspond to the SD; *P < 0.02 by Student’s 2-tailed t test. Data are the aggregate of 5 independent experiments. (B) Representative flow cytometry plots of white blood cell subpopulations in an unaffected individual (UA2) and an XLPDR patient (P1). CD56dim (stage V) NK cell subsets are highlighted by red rectangles. (C) Flow cytometry–based quantification of stage V CD56dim NK cells in unaffected individuals (UA4–UA7, U10, UA11) and XLPDR patients (P1–P5). Horizontal bars represent the mean; error bars correspond to the SD; *P < 0.04 by Student’s 1-tailed t test. Data are the aggregate of 2 independent experiments. (D) Flow cytometry–based quantification of stage VI CD57+ NK cells in unaffected individuals (UA1–UA4) and XLPDR patients (P1, P2, P4, P5). Horizontal bars represent the mean; error bars correspond to the SD; *P < 0.03 by Student’s 2-tailed t test. Data are the representative image of 3 independent experiments. (E) FACS analysis of CD56+CD3– NK cells depicting representative CD57 surface expression in an XLPDR proband (P4, P5) compared with an unaffected control (UA4).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts